StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Lomefloxacin

HCID 3948
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
98079-51-7
Standard-SMILES
CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21
InChIKey
ZEKZLJVOYLTDKK-UHFFFAOYSA-N
Summenformel
C17H19F2N3O3
Durchschnittliche Molmasse
351,35 g/mol
Monoisotopische Masse
351,1394478

Überblick

Lomefloxacin is a fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery. It has a role as an antitubercular agent, an antimicrobial agent and a photosensitizing agent. It is a quinolone, a quinolinemonocarboxylic acid, a N-arylpiperazine, a quinolone antibiotic and a fluoroquinolone antibiotic.

Namen und Bezeichner

Bevorzugter Name
Lomefloxacin
IUPAC
1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid
Englischer Name
Lomefloxacin
Summenformel
C17H19F2N3O3
Molmasse
351.35

Namen und Synonyme

lomefloxacin98079-51-7LomefloxacineLomefloxacinoLomefloxacinumLFLX1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acidSC-47111AL6BR2WJD8V1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid1,4-Dihydro-6,8-difluoro-1-ethyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acidDTXSID4040680
Weitere Namen anzeigen
dm-10ClfimonoSC 47111ALomel9actLEMOFLOXACIN
CHEBI:116278(+-)-1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acidLogifloxOkacinSC-4711lomefloxacinalomenfloxacinRefChem:153984

Datenbank-Bezeichner

CAS
98079-51-7
PubChem CID
3948
DTXSID
DTXSID4040680
ChEMBL
CHEMBL561
ChEBI
CHEBI:116278
UNII
L6BR2WJD8V
EC Number
619-317-6
Nikkaji
J135.046C

Eigenschaften

Berechnete Struktureigenschaften

XLogP
-0,8
Polarare Oberfläche (TPSA)
72,9 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
8
Frei drehbare Bindungen
3
Schwere Atome
25
Formalladung
0
Komplexität
585

Experimentelle und physikochemische Eigenschaften

Drugs · 2 Einträge

Pharmaceuticals -> Anti infectives for systemic use -> Antibacterials for systemic use

Pharmaceuticals -> Antibiotics

LogP2.8
Solubility1.06e-01 g/L
Human DrugsBreast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antibacterial Agents; Quinolones; Fluoroquinolones
Melting Point · 2 Einträge

239-240.5 °C

239 - 240.5 °C

Physical DescriptionSolid
Dissociation Constants5.742
Collision Cross Section · 2 Einträge

191.3 Ų [M+H]+ [CCS Type: TW; Method: calibrated with Waters Major Mix]

191.04 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Schmelzpunkt
239 · 239-240 C
Siedepunkt
542.7 · 542.7±50.0 °C(Predicted)
Dichte
1.342 · 1.342±0.06 g/cm3(Predicted)
storage temp.
-20 °C · Keep in dark place,Sealed in dry,Store in freezer, under -20°C
Löslichkeit
DMSO (Slightly), Methanol (Slightly, Heated, Sonicated)
Aggregatzustand
Solid
pka
-0.25 · -0.25±0.20(Predicted)
Farbe
Pale Yellow to Light Yellow
CAS Datenbank
98079 · 98079-51-7(CAS DataBase Reference)
EPA chemische Informationen
3 · 3-Quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo- (98079-51-7)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P321, P330, P362+P364, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Gefahrenhinweise

Regulatory InformationREACH registered substance: 1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecaboylic acid (EC: 619-317-6)
Hazard Classes and CategoriesAcute Tox. 4 (100%)

Toxikologische Informationen

Drug Induced Liver Injury · 5 Einträge

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

lomefloxacin

DILI Negative

Oral

DOI:10.1016/j.drudis.2019.09.022

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
EPA Human Health Benchmarks for Pharmaceuticals · 6 Einträge

Lomefloxacin

9.3

39.4

The recommended daily dose of lomefloxacin hydrochloride is 400 mg.

Data used to generate the benchmarks include the following: Lowest Daily Dose (LDD): 400 mg/day, Lowest Therapeutic Dose (LTD): 5.0 mg/kg-day, and Screening Dose: 0.002 mg/kg-day.

11-May-06

Sicherheitsdaten

wgk
3
hs_code
29419000
RTECS-Nr.
VB1997500
risk_code
22-36/37/38
Toxizität
LD50 in mice (mg/kg): 245.6 i.v.; >4000 orally (Itoh)
hazard_code
Xn,Xi
safety_code
26-36

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 4 Einträge

S - Sensory organs

J - Antiinfectives for systemic use

QJ - Antiinfectives for systemic use

QS - Sensory organs

Protein Binding10%
Pharmacodynamics · 1 Eintrag

Lomefloxacin is a fluoroquinolone antibiotic used to treat chronic bronchitis, as well as complicated and uncomplicated urinary tract infections. It is also used as a prophylactic or preventative treatment to prevent urinary tract infections in patients undergoing transrectal or transurethral surgical procedures. Flouroquinolones such as lomefloxacin possess excellent activity against gram-negative aerobic bacteria such as <i>E.coli</i> and <i>Neisseria gonorrhoea</i> as well as gram-positive bacteria including <i>S. pneumoniae</i> and <i>Staphylococcus aureus</i>. They also posses effective activity against shigella, salmonella, campylobacter, gonococcal organisms, and multi drug resistant pseudomonas and enterobacter.

Mechanism of Action · 1 Eintrag

Lomefloxacin is a bactericidal fluoroquinolone agent with activity against a wide range of gram-negative and gram-positive organisms. The bactericidal action of lomefloxacin results from interference with the activity of the bacterial enzymes DNA gyrase and topoisomerase IV, which are needed for the transcription and replication of bacterial DNA. DNA gyrase appears to be the primary quinolone target for gram-negative bacteria. Topoisomerase IV appears to be the preferential target in gram-positive organisms. Interference with these two topoisomerases results in strand breakage of the bacterial chromosome, supercoiling, and resealing. As a result DNA replication and transcription is inhibited.

Biological Half-Life8 hours
Metabolism/MetabolitesMinimally metabolized although 5 metabolites have been identified in human urine. 65% appears as the parent drug in urine and 9% as the glucuronide metabolite.
MeSH Pharmacological Classification · 2 Einträge

Substances that inhibit the growth or reproduction of BACTERIA.

Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II.

Absorption, Distribution and Excretion · 3 Einträge

Rapid and nearly complete with approximately 95% to 98% of a single oral dose being absorbed.

The urinary excretion of lomefloxacin was virtually complete within 72 hours after cessation of dosing, with approximately 65% of the dose being recovered as parent drug and 9% as its glucuronide metabolite.

271 mL/min/1.73 m2 [creatinine clearance of 110 mL/min/1.73 m2]

Cellular LocationsCytoplasm
Anwendungen · 2 Einträge

BeschreibungLomefloxacin is a once-daily, third-generation quinolone antibiotic useful in the treatment of bacterial infections. The new fluorinated quinolone does not interfere with the metabolism of theophylline; it is efficacious against pathogens resistant to cephalosporins, penicillins and aminoglycosides.

VerwendenAnti bacterial.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

Ethanol2,3,4-Trifluorobenzenamine2-Ethoxy-malonic acid diethyl esterEssigsäureanhydridN,N-DimethylformamidAcetonDiethylethoxymethylenmalonat4-FluorbenzoesureChlorethanN,N-Diethylethanamin2-Methylpiperazin1,2-DiphenylethanLomefloxacin hydrochlorideTetrafluorbenzol1,2,3-Trifluor-4-nitrobenzolHydrogenchloridBromethanPyridinThionyldichlorid1-Ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-2-quinolinecarboxylic acidNatriumhydrogencarbonat

Ergänzende Hinweise

DefinitionChEBI: A fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery.

Zugehörige Reaktionen

4
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 370714
HRID 370714als Produkt
Reaktionsgleichung von HRID 370715
HRID 370715als Edukt
Reaktionsgleichung von HRID 370716
HRID 370716als Produkt
Reaktionsgleichung von HRID 940195
HRID 940195als Produkt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung